INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  05/27 04:00:00 pm EDT
67.51 USD   +5.34%
05/27INARI MEDICAL, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/18INSIDER SELL : Inari Medical
MT
05/13Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inari Medical Expects Double-Digit Growth in Q4, 2021 Revenue; Shares Soar After-Hours

01/10/2022 | 04:17pm EDT


© MT Newswires 2022
All news about INARI MEDICAL, INC.
05/27INARI MEDICAL, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/18INSIDER SELL : Inari Medical
MT
05/13Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
AQ
05/12TRANSCRIPT : Inari Medical, Inc. Presents at Bank of America 2022 Healthcare Conference, M..
CI
05/04INARI MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
05/04TRANSCRIPT : Inari Medical, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Earnings Flash (NARI) INARI MEDICAL Posts Q1 Revenue $86.8M, vs. Street Est of $83.6M
MT
05/04Inari Medical Reports First Quarter 2022 Financial Results
AQ
05/04Inari Medical, Inc. Revises Revenue Guidance for the Full Year 2022
CI
05/04Inari Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 365 M - -
Net income 2022 -39,1 M - -
Net cash 2022 316 M - -
P/E ratio 2022 -88,8x
Yield 2022 -
Capitalization 3 586 M 3 586 M -
EV / Sales 2022 8,95x
EV / Sales 2023 7,48x
Nbr of Employees 800
Free-Float 85,0%
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 67,51 $
Average target price 111,67 $
Spread / Average Target 65,4%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-26.03%3 586
NOVOCURE LIMITED11.85%8 783
MASIMO CORPORATION-50.99%7 965
GETINGE AB-29.13%7 752
SHOCKWAVE MEDICAL, INC.-2.24%6 240
PENUMBRA, INC.-48.01%5 628